Abstract
Human serum albumin (HSA) is widely utilized in human culture medium to support embryo development for its capacity to carry growth-promoting factors, act as an antioxidant and is a highly stable, non-immunogenic compound. However, HSA is accompanied with risk of disease transmission, and is chemically undefined making it difficult to investigate culture conditions. We examined the effect of two recombinant HSA (rHSA), Optibumin® (InVitria) and Recombumin® (Albumedix), and compared its effects on mouse embryo development and human blastocyst extended culture with undefined HSA-SOLUTION™ (Vitrolife).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
